Study guide
25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs
IJCAHPO Certified Ophthalmic Medical Technologist COMT
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements
1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification
2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology
2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway
3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety
3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety
4 Chapter 4: Ophthalmic History Taking & Clinical Documentation
4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record
5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision
5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction
6 Chapter 6: Tonometry, Keratometry & Pupil Measurement
6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria
7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis
7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment
8 Chapter 8: Refraction, Retinoscopy & Refinement
8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations
9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics
9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations
10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy
10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training
11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation
11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing
12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique
12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics
13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols
13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials
14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)
14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics
15 Chapter 15: Fluorescein Angiography Principles & Technique
15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management
16 Chapter 16: Angiographic Interpretation & Pathology
16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology
17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography
17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers
18 Chapter 18: Ophthalmic Photography & Videography
18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management
19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)
19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging
20 Chapter 20: Biometry, Topography & Corneal Analysis
20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth
21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting
21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems
22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications
22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis
23 Chapter 23: Ocular Pharmacology
23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF
24 Chapter 24: Microbiology & Ocular Specimen Collection
24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection
25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery
25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs
26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery
26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol
27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures
27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)
28 Chapter 28: Ophthalmic Patient Services & Education
28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support
29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance
29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements
25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs
Key Takeaways Explain This Topic AI
Corneal excimer laser photoablation (193 nm) disrupts intermolecular collagen bonds via non-thermal vaporization, with tissue ablation depth approximated by the Munnerlyn formula ( A D ≈ D 2 × S / 3 AD \approx D^2 \times S / 3 A D ≈ D 2 × S /3 ).
Corneal ectasia risk is dictated by the Residual Stromal Bed (RSB, mandatory minimum ≥ 250 μ m \ge 250\ \mu\text{m} ≥ 250 μ m , safe clinical target ≥ 300 μ m \ge 300\ \mu\text{m} ≥ 300 μ m ) and Percent Tissue Altered (PTA), with PTA ≥ 40 % \text{PTA} \ge 40\% PTA ≥ 40% serving as an independent predictor of biomechanical instability.
Femtosecond laser flap creation produces uniform planar flaps with customizable architecture, significantly reducing microkeratome-associated free caps, buttonholes, and epithelial defects.
Surface ablation with PRK plus adjunctive Mitomycin C (0.02% for ablations >50 µm) and SMILE lenticule extraction preserve biomechanical tensile strength and eliminate or reduce flap-related complications.
Posterior chamber phakic IOLs (EVO ICL) correct high ametropia while preserving crystalline lens accommodation; post-surgical anterior chamber vault must measure between 250 and 750 µm to prevent cataracts (low vault) or pupillary block glaucoma (high vault).
Last updated: September 2026
Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs
Core Clinical Mandate: Refractive surgery demands precise biophysical calculations to permanently remodel the ocular refractive apparatus. The ophthalmic medical technologist must master corneal biomechanics, residual stromal bed calculations, flap dynamics, and phakic IOL clearance parameters to prevent catastrophic complications such as post-laser corneal ectasia, interface keratitis, and secondary cataracts.
- Laser Biophysics & The Munnerlyn Ablation Formula
- The 193 nm Argon Fluoride (ArF) Excimer Laser
Modern corneal refractive ablation utilizes the 193 nm Argon Fluoride (ArF) excimer laser operating in the deep ultraviolet spectrum:
Photoablation (Photochemical Vaporization): A single 193 nm photon carries an energy of 6.4 electron volts (eV) , which exceeds the 3.6 eV molecular bond energy of the carbon-carbon and carbon-nitrogen bonds holding corneal collagen and glycosaminoglycans together. The laser breaks intermolecular bonds directly without generating thermal damage or acoustic shockwaves, vaporizing approximately 0.25 µm of corneal tissue per pulse with sub-micron precision.
The Munnerlyn Formula
The central depth of corneal tissue ablated during myopic spherical correction can be estimated mathematically using the Munnerlyn Formula : A D ≈ D 2 × S 3 AD \approx \frac{D^2 \times S}{3} A D ≈ 3 D 2 × S
where:
- A D AD A D = Central ablation depth in microns (µm)
- D D D = Diameter of the optical ablation zone in millimeters (mm)
- S S S = Dioptric sphere corrected in diopters (D)
Clinical Example: Correcting -6.00 D of myopia using a 6.0 mm optical zone: A D ≈ ( 6.0 ) 2 × 6.0 3 = 36 × 6.0 3 = 72 μ m AD \approx \frac{(6.0)^2 \times 6.0}{3} = \frac{36 \times 6.0}{3} = 72\ \mu\text{m} A D ≈ 3 ( 6.0 ) 2 × 6.0 = 3 36 × 6.0 = 72 μ m
If the optical zone is enlarged to 7.0 mm (to avoid night glare in a patient with large scotopic pupils): A D ≈ ( 7.0 ) 2 × 6.0 3 = 49 × 6.0 3 = 98 μ m AD \approx \frac{(7.0)^2 \times 6.0}{3} = \frac{49 \times 6.0}{3} = 98\ \mu\text{m} A D ≈ 3 ( 7.0 ) 2 × 6.0 = 3 49 × 6.0 = 98 μ m
Key Clinical Takeaway: Ablation depth scales with the square of the optical zone diameter ( D 2 D^2 D 2 ) . Enlarging the optical zone dramatically increases stromal tissue removal, directly threatening corneal biomechanical safety.
Loading diagram... Corneal Refractive Surgery Decision & Ectasia Safety Tree
Biomechanical Safety: RSB, PTA & Ectasia Risk Scoring
Iatrogenic corneal ectasia represents the most devastating long-term complication of laser refractive surgery, characterized by progressive biomechanical thinning, steepening, irregular astigmatism, and visual loss resembling advanced keratoconus.
Residual Stromal Bed (RSB) Calculation
The Residual Stromal Bed (RSB) represents the thickness of untouched, intact posterior corneal stroma remaining beneath the ablation bed: RSB = CCT − ( Flap Thickness + Ablation Depth ) \text{RSB} = \text{CCT} - (\text{Flap Thickness} + \text{Ablation Depth}) RSB = CCT − ( Flap Thickness + Ablation Depth )
Universal Absolute Legal Minimum: RSB ≥ 250 μ m \text{RSB} \ge 250\ \mu\text{m} RSB ≥ 250 μ m .
Modern Standard Clinical Safety Target: RSB ≥ 300 μ m \text{RSB} \ge 300\ \mu\text{m} RSB ≥ 300 μ m .
Violating the 250–300 µm threshold severely destabilizes corneal tensile strength, drastically increasing ectasia risk.
Percent Tissue Altered (PTA)
Introduced by Santhiago and colleagues, Percent Tissue Altered (PTA) evaluates the proportional structural alteration of the cornea, integrating both flap thickness and excimer ablation depth relative to baseline central corneal thickness (CCT): PTA = Flap Thickness + Ablation Depth Central Corneal Thickness × 100 % \text{PTA} = \frac{\text{Flap Thickness} + \text{Ablation Depth}}{\text{Central Corneal Thickness}} \times 100\% PTA = Central Corneal Thickness Flap Thickness + Ablation Depth × 100%
Clinical Threshold: A PTA ≥ 40 % \text{PTA} \ge 40\% PTA ≥ 40% is the single most robust independent predictor of post-LASIK ectasia in eyes with normal preoperative topography.
When PTA ≥ 40 % \text{PTA} \ge 40\% PTA ≥ 40% , LASIK is contraindicated, and surface ablation (PRK) or phakic IOLs should be selected instead.
Worked Clinical Example:
- Patient CCT = 510 µm
- Planned Femtosecond Flap = 110 µm
- Planned Ablation Depth = 100 µm (for -7.00 D)
RSB = 510 − ( 110 + 100 ) = 300 μ m \text{RSB} = 510 - (110 + 100) = 300\ \mu\text{m} RSB = 510 − ( 110 + 100 ) = 300 μ m (appears acceptable by traditional criteria)
PTA = ( 110 + 100 ) / 510 × 100 % = 210 / 510 = 41.2 % \text{PTA} = (110 + 100) / 510 \times 100\% = 210 / 510 = \mathbf{41.2\%} PTA = ( 110 + 100 ) /510 × 100% = 210/510 = 41.2%
Clinical Decision: Because PTA > 40 % \text{PTA} > 40\% PTA > 40% , this eye is at high risk for ectasia despite an RSB of 300 µm. LASIK should be aborted in favor of PRK or an ICL.
Preoperative Screening & Risk Scoring
Randleman Ectasia Risk Score System (ERSS): Evaluates 5 factors: topographic pattern (inferior steepening, asymmetric bowtie, forme fruste keratoconus), RSB, patient age (<30 years = higher risk), CCT (<510 µm = high risk), and spherical equivalent refraction.
Tomographic Analysis: Scheimpflug-based imaging (e.g., Oculus Pentacam) evaluates the Belin-Ambrósio Enhanced Ectasia Display (BAD-D) , anterior and posterior corneal elevation against an enhanced reference sphere, and corneal pachymetric progression curves.
- LASIK: Flap Dynamics, Complications & Diffuse Lamellar Keratitis
- Flap Creation: Mechanical Microkeratome vs. Femtosecond Laser
Mechanical Microkeratome (e.g., Hansatome, Moria): Uses an oscillating steel blade. Tends to produce a meniscus-shaped flap (thick at the periphery, thin in the center). Prone to variable flap thickness, free caps (in flat corneas <41 D), and buttonholes (in steep corneas >46 D).
Femtosecond Laser (e.g., IntraLase, VisuMax): Uses ultra-fast infrared laser pulses ( 10 − 15 10^{-15} 1 0 − 15 s) to produce photodisruption . Tightly focused pulses create microscopic cavitation bubbles (CO₂ and water vapor) that cleave corneal tissue in a horizontal lamellar plane, followed by an angled vertical side cut. Produces a uniform planar flap of exact pre-programmed thickness (e.g., 100–110 µm) with beveled edges that resist traumatic dislocation.
Flap Complications & Management
Free Cap: Occurs when the microkeratome passes entirely through the corneal tissue without leaving a hinge (frequently in very flat corneas <41 D). The cap is removed, laser ablation is applied to the bed, and the free cap is repositioned using radial reference ink marks, followed by a bandage contact lens.
Flap Buttonhole: A central hole in the flap occurring when the blade cuts into the epithelium/Bowman's layer (frequently in steep corneas >46 D or during loss of suction). The surgeon must ABORT the procedure immediately without applying laser ablation. The flap is smoothed down and allowed to heal for 3 to 6 months, after which PRK with MMC can be considered.
Flap Striae:
Microstriae: Tiny folds in Bowman's membrane; asymptomatic or managed conservatively with lubricants.
Macrostriae: Full-thickness undulating folds caused by flap slippage. Causes irregular astigmatism and monocular diplopia. Managed by urgent flap lifting, hydration with hypotonic BSS, and mechanical stroking/ironing with a moist lint-free swab.
Diffuse Lamellar Keratitis (DLK / "Sands of the Sahara"):
A sterile, non-infectious inflammatory infiltrate of polymorphonuclear leukocytes (PMNs) accumulating in the lamellar interface between the flap and the stromal bed.
Etiology: Endotoxins from surgical instrument bio-burden, cleaning residues, lubricating oils, or excessive femtosecond laser energy.
Linebarger Clinical Staging & Treatment: (See table below)
Epithelial Ingrowth: Migration of epithelial cells beneath the flap margin into the interface. If progressive, within 2 mm of the visual axis, or causing focal flap melting, the flap must be lifted and cells mechanically scraped from both the bed and the stromal underside of the flap.
DLK Stage Slit-Lamp Biomicroscopic Appearance Visual Symptoms Definitive Management
Stage 1 Fine, white granular infiltrates confined to the flap periphery ; central visual axis entirely clear Asymptomatic; normal visual acuity Intensive topical prednisolone acetate 1% or difluprednate every 1 hour
Stage 2 White granular infiltrates spread centrally into the visual axis (days 2–3); classic "sands of the Sahara" Mild blur; BCVA preserved or down 1 line Hourly high-potency topical steroids; close daily slit-lamp surveillance
Stage 3 Dense, clumped cellular aggregates in central visual axis; reduced stromal transparency Moderate-to-severe visual loss; haze Immediate flap lift and interface washout combined with intensive topical/oral steroids
Stage 4 Stromal melting , fluid accumulation, enzymatic digestion, flap destruction, irregular scarring Severe visual loss; hyperopic shift; permanent astigmatism Flap lift/irrigation; guarded prognosis; requires rigid gas permeable lenses or topography-guided repair
- PRK, SMILE & Phakic Intraocular Lenses
- Photorefractive Keratectomy (PRK) & Surface Ablation
PRK removes the corneal epithelium and applies the excimer laser directly to Bowman's layer and the anterior stroma, completely eliminating flap-related complications:
Epithelial Removal Methods: Mechanical debridement with a blunt spatula, chemical loosening with 20% ethanol in a well for 20 to 30 seconds, a rotary Amoebic brush, or transepithelial laser (tPRK).
Mitomycin C (MMC 0.02%) in PRK:
Mechanism: Applied topically via a circular sponge over the ablated bed for 12 to 60 seconds , followed by copious irrigation with 20 to 30 mL of BSS.
Rationale: Ablations deeper than 50 µm to 75 µm or corrections greater than -4.00 D to -6.00 D disrupt the basement membrane and anterior keratocyte network, triggering intense keratocyte activation, myofibroblast transformation, and disorganized collagen synthesis, presenting clinically as subepithelial corneal haze .
Action: MMC cross-links keratocyte DNA, blocking myofibroblast proliferation and preventing corneal haze.
Small Incision Lenticule Extraction (SMILE)
SMILE (e.g., Zeiss VisuMax) is an all-femtosecond laser intrastromal refractive procedure:
Laser Photodisruption: The femtosecond laser delivers two sequential intrastromal lamellar cuts:
Posterior Refractive Cut: Defines the refractive curvature and power of the lenticule.
Anterior Cap Cut: Creates the corneal cap (typically 100 µm to 140 µm deep).
Side Cut: A small arcuate side-cut incision of 2.0 mm to 4.0 mm width.
Manual Dissection & Extraction: The surgeon uses a micro-dissector to separate the anterior plane, then the posterior plane, and extracts the refractive lenticule through the small incision with micro-forceps.
Clinical Advantages of SMILE:
Biomechanical Superiority: The anterior 40% of the corneal stroma contains the highest density of cross-linked collagen fibers, providing the majority of corneal tensile strength. By preserving this anterior cap intact, SMILE retains more biomechanical strength than LASIK.
Nerve Preservation & Dry Eye: The small 2–4 mm incision severs far fewer corneal subbasal nerve fibers than a 20 mm LASIK flap incision, resulting in significantly less postoperative dry eye and accelerated corneal sensitivity recovery.
Posterior Chamber Phakic IOLs (EVO Visian ICL)
For patients with extreme myopia (-8.00 D to -20.00 D), thin corneas, or elevated ectasia risk (PTA ≥ 40 % \ge 40\% ≥ 40% ), the Implantable Collamer Lens (ICL) provides high-definition refractive correction while preserving the crystalline lens and natural accommodation.
EVO ICL Design: Made of Collamer (a flexible, hydrophilic collagen copolymer). Features a central 0.36 mm aperture ( KS-AquaPORT ), which permits natural physiological aqueous flow from the posterior chamber to the anterior chamber, eliminating the need for preoperative laser peripheral iridotomy (LPI) .
Anterior Chamber Vault: The critical clinical metric evaluated via slit lamp or anterior segment OCT (AS-OCT), representing the clearance between the posterior surface of the ICL and the anterior capsule of the crystalline lens:
Target Optimal Vault: 250 µm to 750 µm (approximately 0.5 to 1.5 central corneal thicknesses).
Low Vault (<250 µm or Direct Contact): Discloses insufficient clearance; friction and impaired aqueous nutrition across the anterior capsule trigger anterior subcapsular cataract (ASC) formation.
High Vault (>750 µm to 1,000+ µm): Pushes the iris forward, narrowing the iridocorneal angle and causing pigment dispersion, pupillary block, and secondary angle-closure glaucoma .
Vault Sizing: Governed by accurate preoperative measurement of horizontal white-to-white (WTW) corneal diameter and anterior chamber depth (ACD, which must be ≥ 3.0 mm \ge 3.0\text{ mm} ≥ 3.0 mm from endothelium to lens capsule).